FDA
approval
· 2023-02-23
FDA Approved: PREVDUO — Original Application (Endo USA)
Summary
The FDA approved PREVDUO, a fixed-dose combination of neostigmine methylsulfate and glycopyrrolate, under an original NDA for reversal of neuromuscular blockade…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for PREVDUO (NEOSTIGMINE METHYLSULFATE AND GLYCOPYRROLATE)